Proteomic and genomic integration identifies kinase and differentiation determinants of kinase inhibitor sensitivity in leukemia cells

Leukemia. 2018 Aug;32(8):1818-1822. doi: 10.1038/s41375-018-0032-1. Epub 2018 Apr 7.

¹ Cell Signalling & Proteomics Group, Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.
² Cancer Immunology Group, Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.
³ Precision Medicine Group, Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.
⁴ Flow Cytometry Core Facility, Barts Cancer Institute, Queen Mary University of London, London, UK.
⁵ Tissue Bank, Barts Cancer Institute, Queen Mary University of London, London, UK.
⁶ Department of Haematological Medicine, King's College London School of Medicine, London, UK.
⁷ Cell Signalling & Proteomics Group, Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK. [email protected].

No abstract available

Publication types